- Kemp G, Rose P, Lurain J, et al. Amifostine pretreatment for protection against cyclophosphamideinduced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. J Clin Oncol. 1996;14:2101-2112.
- Hartmann JT, Fels LM, Knop S, et al. A randomized trial comparing the nephrotoxicity of cisplatin/ ifosfamide based combination cheomotherapy with or without amifostine in patients with solid tumors. Invest Net Drugs. 2000;18:281-289.
- Petrili AS, Oliveira DT, Ginani VC, et al. Use of Amifostine in the therapy of osteosarcoma in children and adolescents. J Pediotr Hemotol Oncol. 2002;24:188-191.
- Borsi JD, Csaki C, Ferencz T, Oster W. Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatin. Anticancer Drugs. 1996;7:121-126.
- Chang CH, Housepian EM, Herben CJr. An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastoma. Radiolog). 1969;93:1351-1359.
- Yuhas JM. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 1980;40:1519-1524.
- Packer RJ, Sutton LN, Elterman R, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg. 1994;81:690-698.
- FjeldborgP, Sorensen J, Helkajer PE. The long term effect of cis diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer. 1986;58:2214-2217.
- Friedman HS, Krischer JP, Burger P, et al. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatrie Onclogy Group randomized phase II study. J Clin Oncol. 1992;10:249-256.
Pediatric Hematology and Oncology
Volume 20, 2003 - Issue 3